Our staff is highly experienced and regularly trained in ICH-GCP guidelines, FDA and all
national regulations. AKP oversees and implements each project as if it was our own. We assure high quality services and results that will meet your timelines and lead your project to success.

AKP has experience in:

  • International and national phases I - IV clinical trials
  • Non-Interventional Studies (NIS)
  • Medical Device Studies (MDS)

and the following therapeutic areas:

  • Cardiovascular diseases
  • CNS/Pain
  • Dermatology
  • Endocrinology
  • Gastroenterology
  • Hyperlipidemia
  • Immunology
  • Infectious diseases
  • Neurology
  • Oncology
  • Orthopedy
  • Pneumology
  • Rheumatology
  • Urology

In Oncology, experience stretches across the following indications:

  • Acute myelogenous leukemia (AML)
  • Adenocarcinoma of the stomach
  • Bronchial carcinoma
  • Chronic lymphocytic leukemia (CLL)
  • Colon carcinoma
  • Colorectal carcinoma
  • Malignant lymphoma
  • Mamma carcinoma
  • Non small cell lung cancer (NSCLC)
  • Pancreas carcinoma
  • Prostata carcinoma

Arbeitskreis Klinische Prüfungen
PD Dr. med. Seiler GmbH
Munzinger Str. 5a
79111 Freiburg/Germany

phone:+49 761 479 40-00
fax:+49 761 479 40-22
mail: info@akp-freiburg.de